MRNA May 2024 135.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:17PM EDT. Market open.
| Previous close | 3.0000 |
| Open | 2.5300 |
| Bid | 2.7100 |
| Ask | 2.8600 |
| Strike | 135.00 |
| Expiry date | 2024-05-31 |
| Day's range | 1.9100 - 2.9400 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.36k |
Investor's Business DailyModerna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Moderna is on the rise after the Food and Drug Administration delayed a decision on its RSV vaccine. But is MRNA stock, once again, a buy?
ZacksModerna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Moderna's (MRNA) RSV vaccine, mRNA-1345's review timeline gets delayed. A decision is now expected by the end of May.
Simply Wall St.While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week ago aren't so fortunate
Long term investing can be life changing when you buy and hold the truly great businesses. And we've seen some truly...
© 2024 Yahoo. All rights reserved.